The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects
Publisher: John Wiley & Sons Inc
E-ISSN: 1879-0844|17|3|273-282
ISSN: 1388-9842
Source: EUROPEAN JOURNAL OF HEART FAILURE, Vol.17, Iss.3, 2015-03, pp. : 273-282
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract